IDH2 and glioblastoma: In this report, we analyzed the original biopsy and subsequent numerous spatially diverse autopsy samples in a case of IDH-mutant GBM with MGMT methylation in a 30-year-old patient who experienced relatively rapid recurrence and short survival interval, using genome-wide methylation profiling and copy number profiling in addition to standard histopathological techniques.